Clinical Trial Update: GLP-1 Receptor Agonist Lixisenatide Versus Exenatide in Patients With Type 2 Diabetes for Glycemic Control and Safety Evaluation, on Top of Metformin [Phase 3]

View source ↗

Summary

Head-to-head Phase 3 trial comparing lixisenatide with exenatide for glycemic control and safety in type 2 diabetes on top of metformin has completed with resul…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Adlyxin (lixisenatide)
• BYETTA (Exenatide)

Snippet

Sponsor: Sanofi | Conditions: Diabetes Mellitus, Type 2 | Phase 3 | Status: COMPLETED | Results posted: 2016-10-11